通过合性带和PROTAC诱导的降解准USP39的结合体蛋白
Daniel Schäfer1,2,3, Cristian Prieto-Garcia4, Jianhui Wang1,2
1Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe-University Frankfurt am Main, Max-von-Laue-Str. 15, D-60438, Frankfurt am Main, Germany.
Angewandte Chemie (International ed. in English)
|December 22, 2025
概括
研究人员开发了针对USP39的新型PROTACs,这是一个关键的结合体蛋白质,与疾病有关. 这些分子有效降解USP39,为癌症和视网膜色素炎等结合相关疾病提供了新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 精确的基因表达调节对细胞功能至关重要;拼接失调与癌症等疾病有关.
- 乌比基特异性蛋白酶39 (USP39),一种非酶体拼接体因子,是具有挑战性的药物标.
研究的目的:
- 为了发现小分子接体,准USP39.
- 开发用于USP39降解的蛋白质分解向嵌合体 (PROTACs).
- 验证USP39作为拼接相关疾病的治疗标.
主要方法:
- 发现基于 thiazole 的 USP39 配体.
- 使用AlphaFold进行结构-活动关系研究.
- 设计和优化针对USP39的PROTACs (例如,USP39_PROTAC_V1) 使用VHL E3结合酶.
- 生物物理和生物化学测定三元复合体形成和结合亲和力.
- 用于USP39降解和全蛋白质组概况的细胞测试.
- 涉及蛋白质酶体和化抑制的机制研究.
主要成果:
- 小分子配体通过其指域选择性地参与USP39.
- USP39_PROTAC_V1在细胞 (1nM) 中有效地降解USP39,具有最小的目标外影响.
- 降解依赖于VHL,对蛋白酶体/缩抑制敏感.
- USP39的枯竭模仿了已知的5'-splice-site-specific拼接模式. 这是一个很好的方法.
结论:
- 通过PROTACs向蛋白质降解是有效的USP39.
- USP39调制为接相关疾病提供了一个有前途的治疗途径,包括癌症和视网膜色素炎.
相关概念视频
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
RNA Splicing
60.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.2K
Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K


